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Abstract
The opiate-receptor antagonist naloxone was administered to rats after passive-avoidance training
either alone or in combination with forced-swim stress. A retention test revealed that while
naloxone enhanced retention when administered alone, it impaired retention when administered in
combination with forced-swim stress. The findings provide evidence for a “protective”
endogenous opioid-based system that, when not blocked pharmacologically, limits enhancement
or impairment of retention under conditions of mild and intense stress, respectively.
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The opioid system has long been implicated in the modulation of memory under stressful
conditions. In humans, the narcotic analgesics are known to impair memory [11]. In animals,
retention of an aversive-training experience (i.e., foot-shock in the passive-avoidance
procedure) is impaired by opiate agonists and enhanced by opiate antagonists administered
shortly after training [4,20]. Thus, the opioid system (or, more specifically, pharmacological
activation of the opioid system) is generally regarded as deleterious to memory.
Impairment of retention through pharmacological stimulation of a stress-related
neurotransmitter system is not limited to the opioid system, however. As with opiate
agonists, serotonin (5-HT) agonists also impair retention [18]. Moreover, like opiate-
receptor blockers, 5-HT-receptor blockers enhance retention in the passive-avoidance
procedure [18,25]. Although these 5-HT-related data might be viewed as consistent with an
inhibitory-modulation system whose blockade enhances and activation impairs memory,
recent studies demonstrate that the magnitude—and indeed the very direction—of the effect
of blockade of the 5-HT system on retention depends upon the level of stress. Specifically,
when animals are exposed to a sufficient stressor after passive-avoidance training (e.g.,
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when animals are exposed to foot-shock from the passive-avoidance training procedure
followed by swim-stress), the effect of 5-HT-receptor blockade on retention shifts from
enhancement to impairment [24].
The reversal in the direction of the modulatory effect of 5-HT-receptor blockade—a reversal
keyed to the level of stress—from enhancement (when the stressor is moderate foot-shock
alone from the passive-avoidance training procedure) to impairment (when the stressor is a
combination of moderate foot-shock and swim-stress) is consistent with the 5-HT-based
system serving as a “limiter” of memory modulation. As such, activation of the endogenous
inhibitory 5-HT system limits the extent to which: (a) lower levels of stress (from moderate
foot-shock alone in the passive-avoidance training procedure) enhance retention and (b)
higher levels of stress (from the combination of moderate foot-shock in the passive-
avoidance training procedure and swim-stress) impair retention. If the “inhibitory” opioid-
modulation system parallels the 5-HT-modulation system in this regard, then the opioid
system should similarly limit memory modulation and its blockade, like blockade of the 5-
HT system, should either enhance or impair retention depending on the level of stress.
In the two present experiments, the effect of blockade of the opioid-modulation system on
retention was determined under conditions of mild and intense stress. Specifically, we
investigated whether opioid-receptor blockade, like 5-HT-receptor blockade, (a) enhances
retention in the passive-avoidance procedure when the stressor is foot-shock alone (from the
training procedure), and (b) impairs retention when the stressor is a combination of foot-
shock (from the training procedure) followed by exposure to forced-swim.
The subjects (n = 75) were male Long–Evans hooded rats weighing 240–280 g at the start of
the experiment. The rats were housed two per cage with access to food and water ad libitum.
The colony room was maintained at 20 °C and was illuminated on a 12-h light–dark cycle
(lights on at 9:00 a.m.). All experiments were conducted between 10:00 a.m. and 12:00 p.m.
In the first experiment rats underwent passive-avoidance training in which they received a
single foot-shock (0.5 mA, 0.5 s) for stepping from a lighted to dark compartment.
Immediately thereafter the animals were randomly assigned to one of two groups: swim and
no swim. Animals in the swim group were exposed to forced-swim stress (15 min in
duration) consisting of placing rats in a cylindrical tank (46-cm tall × 20-cm diameter) with
water (~22 °C) filled to a depth of 30 cm. Animals in the no swim group were, in lieu of
exposure to swim-stress, placed in a quiet, dimly lit room for 15 min. Before being returned
to the animal colony, each group was divided into two subgroups and was administered
either the opiate-receptor blocker naloxone hydrochloride (3 mg/kg, i.p., Sigma Chemical)
or vehicle (0.9% saline, i.p.). The dose of naloxone chosen has been used in previous opioid-
related studies on retention involving the passive-avoidance procedure (20). The next day,
animals received a retention test in which step-through latencies (STLs) served as the
measure of retention (i.e., as STLs increased, retention was taken to increase). If STLs
reached 600 s, the trial was terminated. The experimental protocol was approved by Swarth-
more College’s Institutional Animal Care and Use Committee and was in compliance with
the National Research Council Guide for the Care and Use of Laboratory Animals.
Data were analyzed with one-way analyses of variance which, if statistically significant,
were followed by Protected-t multiple comparison tests. P values (one-tailed) of less than .
05 were taken as statistically significant.
As shown in Fig. 1, naloxone (Nal) administered immediately after exposure to forced-swim
(that is, when the stressor is a combination of foot-shock followed by exposure to forced-
swim) impaired retention: mean STLs in the Swim-Nal group (197.7 ± 54.6 s) were
Schneider et al. Page 2
Behav Brain Res. Author manuscript; available in PMC 2014 January 27.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
markedly lower (t(37) = 2.79, p < .005) than mean STLs in the Swim-Vehicle group (429.2 ±
57.2 s). On the other hand, naloxone administered in the absence of forced-swim (that is,
when the stressor is foot-shock alone from the training procedure) did not enhance retention:
the difference in mean STLs between the No Swim-Nal group (477.9 ± 49.5 s) and the No
Swim-Vehicle group (376.2 ± 78.0 s) did not reach statistical significance (t(37) = 1.19, p > .
05).
It can also be seen in Fig. 1 that forced-swim stress per se had no effect on retention: mean
STLs in the Swim-Vehicle (429.2 ± 57.2 s) and No Swim-Vehicle (376.2 ± 78.0 s) groups did
not differ significantly (t(37) = 0.61, p > .05). The finding that forced-swim impaired
retention only when in the presence of opiate-receptor blockade is consistent with an
endogenous opioid-based modulation system that, when not blocked by naloxone, prevents
swim-stress from impairing retention.
The apparent failure of naloxone to enhance retention under mildly stressful conditions (i.e.,
when foot-shock alone during passive-avoidance training was the stressor) bore further
scrutiny, not the least because animals in the No Swim-Vehicle control group exhibited such
strong retention that a ceiling effect would likely have obscured any enhancing action by
naloxone. To circumvent this problem, an experiment was conducted in which the intensity
of foot-shock during passive-avoidance training was reduced from 0.50 mA (0.5 s) to 0.45
mA (0.5 s). The resultant weaker retention in the vehicle-control groups enabled a clearer
observation of potentially enhancing or impairing action of naloxone on retention.
Fig. 2 reveals that, as in the first experiment, naloxone once again impaired retention when
administered immediately after forced-swim: mean STLs in the Swim-Nal group (155.3 ±
68.9)were significantly lower than mean STLs (325.0 ± 52.0 s) in the Swim-Vehicle group
(t(30) = 1.83, p < .05). In contrast, in the absence of swim-stress, naloxone enhanced
retention: mean STLs in the No Swim-Nal group (523.6 ± 63.6 s) were markedly higher than
mean STLs (275.6 ± 66.7 s) in the No Swim-Vehicle group (t(30) = 2.84, p < .005). These
results indicate that naloxone has a bidirectional effect on retention depending upon the
level of stress.
Finally, as in the first experiment, with regard to the effect of swim-stress per se on
retention, it can be seen in Fig. 2 that mean STLs in the Swim-Vehicle (325.0 ± 52.0 s) and
No-Swim Vehicle (275.6 ± 66.7 s) groups did not differ significantly (t(30) = 0.55, p > .05),
once again consistent with an endogenous opioid-based modulation system that, when
unblocked, is protective of memory.
The results demonstrate that the opiate-receptor blocker naloxone, when administered
immediately after swim-stress, markedly impaired retention in the passive-avoidance
procedure; in contrast, naloxone enhanced retention in the passive-avoidance procedure
when administered in the absence of swim-stress. These findings provide evidence for an
endogenous opioid-based memory-modulation system that, when not blocked
pharmacologically, limits or prevents (a) enhancement of retention after exposure to mild
stress (that is, after exposure to foot-shock alone), and (b) impairment of retention after
exposure to intense stress (that is, after exposure to a compound stressor of foot-shock
followed by forced-swim).
The use of a compound stressor to augment the intensity of stress exposure has been
validated in previous neurochemical studies using activation of the hypothalamopituitary-
adrenal (HPA) axis as a physiological index of stress intensity. It has been demonstrated that
exposure to stress can prime the HPA axis, sensitizing its response to a subsequent novel
stressor [14]. In particular, prior shock has been shown to sensitize the HPA response to
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subsequent swim-stress [3]. Swim-stress, in turn, has been shown to produce elevated levels
of plasma corticosterone [22] and significant alterations in norepinephrine (NE) levels in
limbic nuclei [10,15]. Moreover, in addition to prior shock, the potency of forced-swim may
come from a number of additional factors intrinsic to forced-swim, including psychological
(inescapable stress), physical (forced locomotion) and physiological (hypothermia).
In addition to these effects on glucocorticoids and sympathomimetics, forced-swim stress
has also been shown to target the opioid and serotonergic system; specifically, forced-
swimming alters opioid [17] and 5-HT release [16] in the amygdala. Thus, exposure to
forced-swimming not only meets the criteria of a stressor but produces neurochemical
effects (particularly with respect to corticosterone, adrenergic, serotonergic and opioid
action) consistent with a potential modulator of retention.
As shown in the present study, the determining factor as to whether opiate-receptor blockade
enhances or impairs retention in the passive-avoidance procedure is the intensity of the
stressor. In particular, with regard to impairment of retention produced by naloxone, the use
of a compound stressor—the combined stressor of foot-shock from training followed by
exposure to forced-swimming—revealed the “protective” nature of the inhibitory-opioid-
based modulatory system (in that the system, when not blocked by naloxone, appears to
function to prevent impairment of retention under conditions of intense stress). The
protective ability of another modulatory system, an inhibitory-5-HT-based system, has
previously been uncovered through the use of this compound stressor [24], and it seems
reasonable to assume that the underlying “protective” mechanisms are similar. Based on the
results of this previous study, combined with the present work, we propose that the absence
of an effect of swim-stress on retention in the passive-avoidance procedure results from an
interaction among multiple memory modulation systems, namely, an excitatory-based
modulation system (potentially including corticosterone, epinephrine, acetylcholine and
norepinephrine) well-described by others [6,7,9,23] and two inhibitory systems: a 5-HT-
based system and the opioid-based system described herein.
Within this context, varying levels of stress are proposed to activate the excitatory-based
modulation system to varying degrees with the ultimate effect (or, from the alternative
perspective, absence of an effect) on retention a function of the interaction between (a) the
inverted U-shaped dose response relationship well established for the excitatory-based
system [7], and (b) the inhibitory serotonergic and opioid modulatory systems. Although
low levels of activation of the excitatory-based system alone have little or no effect on
retention, intermediate levels enhance retention and high levels impair retention (the last via
over-activation of the excitatory-based system), the net effect of stress on retention is
critically dependent on the simultaneous activation of the excitatory and inhibitory systems
with the protective-inhibitory systems holding the excitatory-based system in check.
Under the sufficiently intense levels of stress produced in the present study by the combined
effect of foot-shock and forced-swimming, the excitatory-based system is presumably over-
activated such that, were it not for the simultaneous activation of the inhibitory-opioid-based
system, it would presumably impair retention. Thus, by reducing over-activation of the
excitatory-based system and the impairment of retention that would otherwise result, the
opioid system protects retention. Under these conditions, pharmacological blockade of the
opioid-based system impairs retention by enabling over-activation of the excitatory-based
system to occur unchecked.
This theoretical framework can also explain the enhancement of retention by naloxone in the
absence of swim-stress. Specifically, the unblocked, endogenous opioid-based system,
activated by the mild stress of foot-shock during passive-avoidance training, functions to
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limit enhancement of retention by opposing the simultaneous activation (as opposed to over-
activation) of the excitatory-based system. Accordingly, blockade of the inhibitory-opioid-
based system under mildly stressful conditions enhances retention by reducing opposition to
the excitatory-based (facilitating) system.
In this regard, previous studies have not only shown enhancement of retention by naloxone
under mildly stressful conditions, but amelioration of this enhancement through concurrent
blockade of the excitatory-based system (specifically, the adrenergic system) via infusion of
a β-adrenergic blocker directly into the amygdala [12,20]. As further support for NE as one
of the excitatory neurotransmitters or hormones involved in modulation of memory by the
opioid system, systemically administered naloxone has been shown to increase NE release in
the basolateral amygdala [21]; moreover, consistent with the over-activation view proposed
in the present study, the magnitude of the increase was keyed to the level of stress that
preceded the opiate antagonist’s administration. However, whether or not activation or over-
activation of the NE-based (as opposed to corticosterone-based or acetylcholine-based, for
example) excitatory system accounts for enhancement or impairment of retention produced
by naloxone in the present study remains to be determined.
Based on the above-cited studies, the amygdala emerges as a strong candidate for at least
one brain site in which the opioid and adrenergic systems might interact to regulate memory
modulation under stressful conditions. Indeed, the amygdala is rich in all major subtypes of
opioid receptors [19], NE release in the amygdala is increased by stress [5], and NE release
in the amygdala is inhibited by μ-opioid agonists [21]. Moreover, intra-amygdala infusion of
β-endorphin impairs retention and intra-amygdala infusion of naloxone enhances retention in
the passive-avoidance procedure [4,12]. The effects of κ-opioid agonists on memory have
been mixed: while ineffective in rats [13], κ agonists impair retention in mice [1], an effect
that is mediated by the amygdala [2]. Thus, there is strong evidence that the amygdala is
involved in stress-induced memory modulation by multiple opioid systems. However, before
conclusions can be drawn with regard to the specific opioid-receptor subtypes involved in
mediating the effect of swim-stress on memory in the present study, studies utilizing more
selective opioid-receptor antagonists will be necessary.
In view of the relative importance given to the role of the opioid system in mediating the
effect of stress on memory modulation, it is perhaps surprising that the opioid system as
protective of memory modulation under stressful conditions—specifically, limiting
impairment of retention under highly stressful conditions—was not uncovered earlier. One
reason—the one that distinguishes the present study—may be methodology: the unique
combination of different levels of stress with a drug (nalox-one) that blocks rather than
activates stress-related neurochemical systems.
On the other hand, although the notion of stress-dependent protection produced by the
opioid system is new, the finding of stress-dependent enhancement and impairment of
retention produced by stress-related neurochemicals in general is not. Earlier studies have
found that, with dosage held constant, exogenously administered epinephrine or
adrenocorticotropic hormone (ACTH) enhances retention in animals trained to avoid weak
shock but impairs retention in animals trained to avoid intense shock [8,9].
Thus, the results of the present study parallel the results of previous studies, albeit with one
major difference. In contrast to exogenous activation (epinephrine and ACTH) of the
excitatory-based system utilized in previous studies, blockade of the inhibitory-based system
utilized in the present study revealed the “protective” nature of an endogenous opioid-based
system (a system that, when not blocked, appears to function to prevent enhancement or
impairment of retention under conditions of mild and intense stress, respectively).
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In conclusion, the present results not only demonstrate the protective nature of the opioid
system, possibly via a dynamic interaction with an excitatory-based memory modulation
system, but also provide a theoretical framework in which to view the protective role played
by the endogenous inhibitory-modulation systems in mediating the effect of stress on
memory.
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Fig. 1.
Higher shock intensity: impairment of retention by naloxone. Step-through latency (mean ±
SEM) in seconds on the test trial for the No Swim-Vehicle group (n = 9), No Swim-Nal group
(n = 11), Swim-Vehicle group (n = 10), and Swim-Nal group (n = 11). With shock intensity
set at 0.5 mA (0.5 s) during passive-avoidance training, naloxone impaired retention when
administered after swim-stress but did not enhance retention when administered in the
absence of swim-stress. *p < .005 compared with the corresponding vehicle group. p-values
shown are for significant protected-t tests following one-way ANOVA; F(3, 37) = 4.54, p
< .01.
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Fig. 2.
Lower shock intensity: impairment or enhancement of retention by naloxone. Step-through
latency (mean ± SEM) in seconds on the test trial for the No Swim-Vehicle group (n = 9), No
Swim-Nal group (n = 9), Swim-Vehicle group (n = 8), and Swim-Nal group (n = 8). With
shock intensity set at 0.45 mA (0.5 s) during passive-avoidance training, naloxone impaired
retention when administered after swim-stress and enhanced retention when administered in
the absence of swim-stress. *p < .05; **p < .005 compared with the corresponding vehicle
group. p-values shown are for significant protected-t tests following one-way ANOVA; F(3,
30) = 5.90, p < .01.
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